Who Paid My Doc
Cardiva VASCADE MVP VVCS 6-12F
Device Devices
PDI M729800612C0
General payments
$1,388,061
Research payments
$945,393
Through program year 2025, $1,388,061 in general payments and $945,393 in research payments were reported against Cardiva VASCADE MVP VVCS 6-12F (Devices).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $206,968 | 2,967 |
| 2024 | General | $156,943 | 3,969 |
| 2023 | General | $152,839 | 3,634 |
| 2023 | Research | $2,500 | 1 |
| 2022 | General | $187,631 | 2,533 |
| 2022 | Research | $88,051 | 29 |
| 2021 | General | $683,680 | 1,983 |
| 2021 | Research | $854,842 | 93 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 52 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
15,086 general · 123 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.